Uncovering Institutional Buying In Gilead Sciences, Inc (NASDAQ: GILD)
Currently, there are 1.25B common shares owned by the public and among those 1.24B shares have been available to trade. The company’s stock has a 5-day price change of 1.43% and -6.10% over the past three months. GILD shares are trading 17.91% year to date (YTD), with the 12-month market performance up to 71.51% higher. […]
Is There More Upside Ahead For Gilead Sciences, Inc (NASDAQ: GILD)
Gilead Sciences, Inc (GILD) concluded trading on Thursday at a closing price of $111.11, with 5.59 million shares of worth about $621.4 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 23.20% during that period and on May 29, 2025 the price saw a […]
Gilead Sciences, Inc (GILD) Testing Investors’ Patience Right Now
Currently, there are 1.25B common shares owned by the public and among those 1.24B shares have been available to trade. The company’s stock has a 5-day price change of 2.25% and 0.86% over the past three months. GILD shares are trading 14.93% year to date (YTD), with the 12-month market performance up to 58.42% higher. […]
Do Gilead Sciences, Inc (NASDAQ: GILD) Fit In A Value Investing Philosophy?
Currently, there are 1.25B common shares owned by the public and among those 1.24B shares have been available to trade. The company’s stock has a 5-day price change of 0.98% and 8.73% over the past three months. GILD shares are trading 12.40% year to date (YTD), with the 12-month market performance up to 59.92% higher. […]
Gilead Sciences, Inc (NASDAQ: GILD): Hunting Genuine Value In Market Debris
Currently, there are 1.25B common shares owned by the public and among those 1.24B shares have been available to trade. The company’s stock has a 5-day price change of -6.07% and -0.11% over the past three months. GILD shares are trading 5.97% year to date (YTD), with the 12-month market performance up to 49.82% higher. […]
Gilead Sciences, Inc (GILD) Volatility Spurs A Quest For Clarity
Currently, there are 1.25B common shares owned by the public and among those 1.24B shares have been available to trade. The company’s stock has a 5-day price change of -1.31% and 10.85% over the past three months. GILD shares are trading 11.69% year to date (YTD), with the 12-month market performance up to 53.92% higher. […]
Uncovering Institutional Buying In Gilead Sciences, Inc (NASDAQ: GILD)
Currently, there are 1.25B common shares owned by the public and among those 1.24B shares have been available to trade. The company’s stock has a 5-day price change of 0.68% and 13.60% over the past three months. GILD shares are trading 12.95% year to date (YTD), with the 12-month market performance up to 55.88% higher. […]
Gilead Sciences, Inc (GILD): A Great Stock For Handling Current Market Conditions?
Currently, there are 1.25B common shares owned by the public and among those 1.24B shares have been available to trade. The company’s stock has a 5-day price change of 2.41% and 16.13% over the past three months. GILD shares are trading 14.41% year to date (YTD), with the 12-month market performance up to 55.25% higher. […]
Gilead Sciences, Inc. (NASDAQ: GILD): Stock That Needs Special Handling
Currently, there are 1.25B common shares owned by the public and among those 1.24B shares have been available to trade. Insiders at the company have transacted a total of 63 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 34 of these insider trades were purchases, […]
Gilead Sciences, Inc. (GILD) Testing Investors’ Patience Right Now
Currently, there are 1.25B common shares owned by the public and among those 1.24B shares have been available to trade. Insiders at the company have transacted a total of 66 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 37 of these insider trades were purchases, […]